Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Synergistic effect of a novel cyclic pentadepsipeptide, neoN-methylsansalvamide, and paclitaxel on human multidrug resistance cancer cell lines.

Lee HS, Phat C, Choi SU, Lee C.

Anticancer Drugs. 2013 Jun;24(5):455-60. doi: 10.1097/CAD.0b013e32835f060d.

PMID:
23411682
2.

Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.

Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.

Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.

PMID:
18845169
3.
4.

Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.

Lee SY, Rhee YH, Jeong SJ, Lee HJ, Lee HJ, Jung MH, Kim SH, Lee EO, Ahn KS, Ahn KS, Kim SH.

Environ Toxicol. 2011 Aug;26(4):424-31. doi: 10.1002/tox.20568. Epub 2010 Mar 1.

PMID:
20196146
5.

Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.

Roomi MW, Kalinovsky T, Roomi NW, Rath M, Niedzwiecki A.

Oncol Rep. 2012 Jan;27(1):17-27. doi: 10.3892/or.2011.1471. Epub 2011 Sep 22.

PMID:
21947138
6.

Optimization of culture conditions of Fusarium solani for the production of neoN-methylsansalvamide.

Lee HS, Phat C, Nam WS, Lee C.

Biosci Biotechnol Biochem. 2014;78(8):1421-7. doi: 10.1080/09168451.2014.921554. Epub 2014 Jun 12.

PMID:
25130748
7.

Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.

Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z.

J Biomol Screen. 2010 Mar;15(3):287-96. doi: 10.1177/1087057109359422. Epub 2010 Feb 11.

PMID:
20150589
8.

Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity.

Lee BH, Lee CO, Kwon MJ, Yi KY, Yoo SE, Choi SU.

Anticancer Drugs. 2003 Feb;14(2):175-81.

PMID:
12569305
9.

Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening.

Wesolowska O, Paprocka M, Kozlak J, Motohashi N, Dus D, Michalak K.

Anticancer Res. 2005 Jan-Feb;25(1A):383-9.

10.
12.

Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer.

Duan Z, Li X, Huang H, Yuan W, Zheng SL, Liu X, Zhang Z, Choy E, Harmon D, Mankin H, Hornicek F.

J Med Chem. 2012 Apr 12;55(7):3113-21. doi: 10.1021/jm300117u. Epub 2012 Mar 22.

PMID:
22400811
13.

Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.

Kars MD, I┼čeri OD, Gunduz U, Molnar J.

Chemotherapy. 2008;54(3):194-200. doi: 10.1159/000140462. Epub 2008 Jun 18.

PMID:
18560226
14.

The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.

Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.

Gynecol Oncol. 2004 Jul;94(1):67-73.

PMID:
15262121
15.

Reversal of multidrug resistance in cancer cells by novel asymmetrical 1,4-dihydropyridines.

Firuzi O, Javidnia K, Mansourabadi E, Saso L, Mehdipour AR, Miri R.

Arch Pharm Res. 2013 Nov;36(11):1392-402. doi: 10.1007/s12272-013-0149-8. Epub 2013 May 15.

PMID:
23674129
16.

Isolation of limonoids and alkaloids from Phellodendron amurense and their multidrug resistance (MDR) reversal activity.

Min YD, Kwon HC, Yang MC, Lee KH, Choi SU, Lee KR.

Arch Pharm Res. 2007 Jan;30(1):58-63.

PMID:
17328243
17.

Radioiodinated agents for imaging multidrug resistant tumors.

Kortylewicz ZP, Augustine AM, Nearman J, McGarry J, Baranowska-Kortylewicz J.

Med Chem. 2009 Mar;5(2):171-81.

PMID:
19275716
18.

Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.

Stein U, Walther W, Shoemaker RH.

J Natl Cancer Inst. 1996 Oct 2;88(19):1383-92.

PMID:
8827016
19.

Protein kinase C isoform expression and activity alter paclitaxel resistance in vitro.

Chen L, Burger RA, Zaunbrecher GM, Cheng H, Lincoln AJ, Mallarino MC, Monk BJ, Khan SA.

Gynecol Oncol. 1999 Feb;72(2):171-9.

PMID:
10021296
20.

FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells.

Hung TH, Chen CM, Tseng CP, Shen CJ, Wang HL, Choo KB, Chong KY.

Int J Biochem Cell Biol. 2014 Aug;53:55-65. doi: 10.1016/j.biocel.2014.04.011. Epub 2014 May 9.

PMID:
24814288

Supplemental Content

Support Center